We are live on
!
Find out more
DWM
Destination Wealth Management Portfolio holdings
AUM
$3.85B
1-Year Est. Return
13%
This Fund
S&P 500
This Quarter
Est. Return
+2.3%
1 Year Est. Return
+13%
3 Year Est. Return
+43.89%
5 Year Est. Return
+47.98%
10 Year Est. Return
+171.22%
AUM
$1.04B
AUM Growth
$0
(0%)
Cap. Flow
-$131K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
41.56%
Holding
127
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lineage Cell Therapeutics
LCTX
|
+$127K |
| 2 |
UBFO
United Security Bancshares
UBFO
|
+$4.41K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 8.27% |
| 2 | Financials | 6.25% |
| 3 | Technology | 5.42% |
| 4 | Communication Services | 4.28% |
| 5 | Consumer Staples | 3.33% |
Similar funds
AP
TRCT
HFCIX
TFM
AC
GAMH
IP
FLSM
Destination Wealth Management's Q1 2016 Portfolio in Review
As of Q1 2016, Destination Wealth Management held 127 positions worth $1.04B, unchanged from the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 0%. Destination Wealth Management opened no new positions and made no exits, leaving the 127-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 8.3% of assets, unchanged from a quarter earlier, followed by Financials and Technology.
- Destination Wealth Management's biggest Q1 2016 reduction was Lineage Cell Therapeutics, cutting an estimated $127K.
- Destination Wealth Management's ten largest holdings make up 42% of its $1.04B portfolio in Q1 2016.
- Destination Wealth Management opened 0 new positions and closed 0 in Q1 2016.
- Destination Wealth Management's portfolio value was unchanged quarter-over-quarter at $1.04B.
Based on Destination Wealth Management's 13F filing for Q1 2016, filed 20 Apr 2016.